Bacteroides dorei as Next Generation Probiotics

It is increasingly recognized that Bacteroides dorei (B. dorei) plays a pivotal role in the development of several kinds of diseases such as cardiovascular disease and metabolic disease. Creative Biolabs has rich experience in developing and producing live biotherapeutic products, with both aerobic and anaerobic organisms. We now provide customized B. dorei-based drug discovery services and products for global clients. Our commercial products are strains of B. dorei which have been originally isolated from healthy human donors. They are grown in our cGMP-certified facility, encapsulated, and delivered selectively to the gut where they exert their therapeutic effects. Each strain is selected for its functionality in a similar way to how a small-molecule or biologic is selected to perform a specific role in combating a disease.